Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

57 results about "SIDS - Sudden infant death syndrome" patented technology

Sudden infant death syndrome. Sudden infant death syndrome (SIDS), also known as cot death or crib death, is the sudden unexplained death of a child less than one year of age. Diagnosis requires that the death remains unexplained even after a thorough autopsy and detailed death scene investigation. SIDS usually occurs during sleep.

Wireless medical telemetry system and methods using radio frequency energized biosensors

A system is provided that furnishes physiological or biomechanical parameters from sensors placed upon or within a subject. The system comprises radio frequency energized biosensor (RFEB) devices that are powered by and communicate with an external receiver and monitoring apparatus. One embodiment of the system provides for infant monitoring in a crib utilizing RFEB devices incorporated into a dermal patch. Said patch communicates with a receiver suspended above the crib and alerts of early warning signs of sudden infant death syndrome (SIDS) or other physiologic abnormalities. Another embodiment comprises implantable RFEB devices that relay information related to the condition of an internal tissue, organ, or cavity to an external receiver, monitor, and recorder. Other embodiments include wearable sensors for detecting a subject attempting to get out of bed, dislodge medical equipment, or stray from a given location.
Owner:ZAND JASON MATTHEW

Probiotic lactic acid bacterium to treat bacterial infections associated with SIDS

Compositions including a non-pathogenic lactic acid-producing bacteria, such as a Bacillus species, spores or an extracellular product of B. coagulans, formulated for oral administration to the intestinal tract for inhibiting bacterial gastrointestinal infections are described. Methods and systems using the compositions for treating gastrointestinal infections, particularly sudden infant death syndrome (SIDS) are also disclosed.
Owner:GANEDEN BIOTECH

Use of somatostatin receptor agonists in the treatment of human disorders of sleep hypoxia and oxygen deprivation

InactiveUS20030083241A1Inhibition of activationBroad anti-inflammatory activityAntinoxious agentsSomatostatinsOxygen deprivationHypopnea
The invention relates to a method of treating diverse human disorders that may arise, in part, out of sleep hypoxia and oxygen deprivation occurring in the context of sleep apnea / hypopnea disturbances. The disorders that may be treated by the invention comprise gastroesophageal reflux disease (GERD), asthma-associated gastroesophageal reflux (GER), GER-associated asthma, asthma, cardiomyopathy, cardioarrhythmia, congestive heart failure, sudden infant death syndrome, and diverse neurologic conditions. The mode of treatment uses somatostatin receptor ligands (SstRLs), particularly somatostatin-receptor agonists. The invention concerns the method of treatment utilizing, and compositions comprising SstRLs and somatostatin receptor agonists, including agonists of the somatostatin receptor types 2 and 5, particularly, the type 2A receptor (SsR-2A), including octreotide and lanreotide.
Owner:YOUNG CHARLES W

Method And Device For Monitoring The Risks For Sudden Infant Death Syndrom And For Positional Plagiocephaly

A portable monitoring device for monitoring of the short term, mid term and long term risks of Sudden Infant Death Syndrome (SIDS) and to estimate the risk of onset of positional plagiocephaly. The monitoring device acquires one or more signals associated to the typical breath and positioning patterns of an infant through a tri-axial accelerometer, and registers the data in electronic format, where statistical analysis of the signal and pattern recognition are performed in real time by a processing unit. The device monitors the breath activity of an infant in various conditions, alerting a caregiver when a potentially dangerous situation is detected. The monitoring is attached to the clothes of the infant. Statistical analysis of the registered data is performed for quantifying the long term SIDS risk, the risk of plagiocephaly and for optimizing the functional parameters of the monitoring device.
Owner:MONDEVICES

Method and Apparatus for Infant Sleep Apnea Monitoring and Data Analysis

Methods and apparatuses for monitoring breathing pattern by monitoring and analyzing data that are the results of pressure changes in an air bed due to amount of air inhaled and exhaled and the chest expansion and contraction of an infant. The changes in pressure over time can be recorder, modeled and sent to be analyzed for fault detection in breathing pattern. As a result the abnormalities in the breathing pattern can be detected and parents and pediatrics can be warned in case of an Apparent Life-Threatening Event (ALTE) to prevent Sudden Infant Death Syndrome (SIDS).
Owner:MIRTALEBI MOHSEN +1

Infant Sleeping Area Ventilation System For the Prevention of Sudden Infant Death Syndrome

A ventilation system that includes a fan for providing fresh air within an infant's sleeping area. The fan may be mounted to the infant's sleeping device and may include fan guards surrounding the fan for increased safety. The ventilation system may include a sensing device for monitoring the conditions within the infant's sleeping area. The sensing device may monitor the oxygen level, the carbon dioxide level, and the presence of smoke. The sensing device may monitor for additional toxic gasses or hazardous conditions within the infant's sleeping area. The ventilation system may further include a remote receiver that receives signals from the sensing device if a hazardous condition exists within the infant's sleeping area. The ventilation system may further include local and remote alarms configured to provide notification of a hazardous condition within the infant's sleeping area.
Owner:REX ENTERPRISES

Spacer fabric for mattress pad

A spacer fabric in combination with an infant mattress pad is provided. The spacer fabric has three parts or components knitted together to form a fabric with two breathable outer fabric layers and a breathable cushioned middle defined by yarns interconnecting the two layers. The spacer fabric is incorporated into an infant mattress pad in order to create an infant safety and comfort system designed to help reduce the risk of sudden infant death syndrome (SIDS) and also to provide infants with enhanced comfort.
Owner:SCHLUSSEL JEREMY

Novel agents for preventing and treating disorders involving modulation of the RyR receptors

The present invention provides novel compounds of Formula I and salts, hydrates, solvates, complexes, and prodrugs thereof. The present invention further provides methods for synthesizing compounds of Formula I. The invention additionally provides pharmaceutical compositions comprising the compounds of Formula I and methods of using the pharmaceutical compositions of Formula I to treat and prevent disorders and diseases associated with the RyR receptors that regulate calcium channel functioning in cells. Such disorders and diseases include, by way of example only, cardiac disorders and diseases, skeletal muscular disorders and diseases, cognitive disorders and diseases, malignant hyperthermia, diabetes, and sudden infant death syndrome. Cardiac disorder and diseases include, but are not limited to, irregular heartbeat disorders and diseases; exercise-induced irregular heartbeat disorders and diseases; sudden cardiac death; exercise-induced sudden cardiac death; congestive heart failure; chronic obstructive pulmonary disease; and high blood pressure. Irregular heartbeat disorders and diseases include and exercise-induced irregular heartbeat disorders and diseases include, but are not limited to, atrial and ventricular arrhythmia; atrial and ventricular fibrillation; atrial and ventricular tachyarrhythmia; atrial and ventricular tachycardia; catecholaminergic polymorphic ventricular tachycardia (CPVT); and exercise-induced variants thereof. Skeletal muscular disorder and diseases include, but are not limited to, skeletal muscle fatigue, exercise-induced skeletal muscle fatigue, muscular dystrophy, bladder disorders, and incontinence. Cognitive disorders and diseases include, but are not limited to, Alzheimer's Disease, forms of memory loss, and age-dependent memory loss.
Owner:THE TRUSTEES OF COLUMBIA UNIV IN THE CITY OF NEW YORK

Treatment for sleep apnea

The present invention relates to compositions and methods of alleviating a symptom of sleep apnea, snoring associated with and independent of sleep apnea, and / or sudden infant death syndrome by administering oxytocin. Specifically, the invention includes a method of administering oxytocin or a salt thereof to an animal in order to treat obstructive sleep apnea, snoring associated with and independent of sleep apnea, and sudden infant death syndrome.
Owner:GOULD JEFFREY

Novel agents for preventing and treating disorders involving modulation of the RyR receptors

The present invention provides novel compounds of Formula I and salts, hydrates, solvates, complexes, and prodrugs thereof. The present invention further provides methods for synthesizing compounds of Formula I. The invention additionally provides pharmaceutical compositions comprising the compounds of Formula I and methods of using the pharmaceutical compositions of Formula I to treat and prevent disorders and diseases associated with the RyR receptors that regulate calcium channel functioning in cells. Such disorders and diseases include, by way of example only, cardiac disorders and diseases, skeletal muscular disorders and diseases, cognitive disorders and diseases, malignant hyperthermia, diabetes, and sudden infant death syndrome. Cardiac disorder and diseases include, but are not limited to, irregular heartbeat disorders and diseases; exercise-induced irregular heartbeat disorders and diseases; sudden cardiac death; exercise-induced sudden cardiac death; congestive heart failure; chronic obstructive pulmonary disease; and high blood pressure. Irregular heartbeat disorders and diseases include and exercise-induced irregular heartbeat disorders and diseases include, but are not limited to, atrial and ventricular arrhythmia; atrial and ventricular fibrillation; atrial and ventricular tachyarrhythmia; atrial and ventricular tachycardia; catecholaminergic polymorphic ventricular tachycardia (CPVT); and exercise-induced variants thereof. Skeletal muscular disorder and diseases include, but are not limited to, skeletal muscle fatigue, exercise-induced skeletal muscle fatigue, muscular dystrophy, bladder disorders, and incontinence. Cognitive disorders and diseases include, but are not limited to, Alzheimer's Disease, forms of memory loss, and age-dependent memory loss.
Owner:THE TRUSTEES OF COLUMBIA UNIV IN THE CITY OF NEW YORK

Non-invasive, wireless, portable device applicable to the finger to reduce the risk of sudden infant death syndrome and reduce the risk of apnea, slower heart rate, and heart arrest in all age groups

A non-invasive, wireless, portable device is applicable to the finger in order to reduce the risk of the sudden infant death syndrome and to reduce the risk of apnea, slower heart rate, and heart arrest in all age groups. The device is placed tightly on the distal end of a user's finger. As it is placed on the finger, this device may be inside a fabric cap attached to a glove of different sizes. This device measures blood oxygen saturation and heart rate through a sensor that is preferably a pulse oximeter. When any of these parameters falls below certain user-predetermined thresholds, an electric discharge is delivered to stimulate the user's reaction and a local and / or remote alarm is fired. In certain applications, the device is adequate to make the sleeping user react, and in others to prevent the user from falling asleep.
Owner:APN INTPROP LLC

Di-substituted amides for enhancing glutamatergic synaptic responses

This invention relates to compounds, pharmaceutical compositions and methods for use in the prevention and treatment of cerebral insufficiency, including enhancement of receptor functioning in synapses in brain networks responsible for basic and higher order behaviors. These brain networks, which are involved in regulation of breathing, and cognitive abilities related to memory impairment, such as is observed in a variety of dementias, in imbalances in neuronal activity between different brain regions, as is suggested in disorders such as Parkinson's disease, schizophrenia, respiratory depression, sleep apneas, attention deficit hyperactivity disorder and affective or mood disorders, and in disorders wherein a deficiency in neurotrophic factors is implicated, as well as in disorders of respiration such as overdose of an alcohol, an opiate, an opioid, a barbiturate, an anesthetic, or a nerve toxin, or where the respiratory depression results form a medical condition such as central sleep apnea, stroke-induced central sleep apnea, obstructive sleep apnea, congenital hypoventilation syndrome, obesity hypoventilation syndrome, sudden infant death syndrome, Rett syndrome, spinal cord injury, traumatic brain injury, Cheney-Stokes respiration, Ondines curse, Prader-Willi's syndrome and drowning. In a particular aspect, the invention relates to compounds useful for treatment of such conditions, and methods of using these compounds for such treatment.
Owner:CORTEX PHARMA INC

Neonatal cranial support bonnet

A neonatal cranial support bonnet is configured to prevent a premature child's head from deforming under the force of its own weight, because of underdeveloped cranial plates. The bonnet includes a thin cotton shell with contoured gel packs inside. The gel packs are configured to distribute weight around the skull and eliminate or reduce high-pressure points so as to maintain proper shape of the cranium. The bonnet is also configured to not interfere with development, and to not obstruct airways for breathing, so as to meet current Sudden Infant Death Syndrome prevention guidelines.
Owner:BOARD OF RGT THE UNIV OF TEXAS SYST

Stochastic resonance and brownian motion for the reduction of sudden infant death syndrome (SIDS)

Inventive embodiments include a system for preventing Sudden Infant Death Syndrome (SIDS) in an infant, by the application of Stochastic Resonance neurological stimuli. The system includes a crib mattress and copper noise grids, wherein the copper noise grids are embedded in the crib mattress. The system also includes a mechanism for generating time controlled white noise and time controlled cyclic signals, combined with a multitude of varying frequencies and harmonics, wherein the mechanism is adjustable for measured local (near crib) white noise power density levels, the mechanism further adjustable for diurnal and seasonal white noise power density level changes. The system also includes circuitry effective for producing positive and negative adjustable DC voltage levels.
Owner:ELEMENT 1 SYST

Computer powered wire(less) ultra-intelligent real-time monitor

A device (1)(2) and method to monitor, in real time, one or more variables by an at least 2500 hour water proof sensor / transmitter, not requiring recharge, placed at the source where data are automatically collected and transmitted by wire or wireless means (2A)(2B) to a battery-free computer-powered (2C) receiver connected to a computer, where software continuously analyzes and charts the data. The software auto and cross correlates the variables, continuously updates and displays the data on simple aggregate charts (4A) or decomposes the data and displays them on newly created common cause charts (4B)(4C) of internal systematically related effects and newly created special cause charts (4D)(4E) of external random unrelated effects, including summary data, and creates graduated progressive sound, color, print and world wide, fax, email and telephone alarm signals when the chart values exceed user specified limits, either in terms of actual units (4B)(4D) or standard deviations (4C)(4E), or when any particular pattern occurs. The device helps determine ahead of time, when the source of the monitored variables is functioning abnormally. Advance warning thus obtained, is used to initiate corrective action (3A)(3B)(3C)(3D) so as to prevent failure at the source that is generating the variables. Examples of failure that it helps prevent include but are not limited to, sudden infant death due to sudden infant death syndrome in human babies, heart or respiratory failure in any human being who is either at rest or moving around within a specified area, failure in industrial machines or measuring equipment, manufacturing defects and financial irregularities.
Owner:RIDLEY ALFRED DENNIS

Phosphodiesterase 4D in the ryanodine receptor complex protects against heart failure

InactiveUS20060293266A1Effective treatmentBiocideOrganic active ingredientsPhosphodiesteraseRyanodine receptor complex
The present invention provides compositions useful for treating and preventing ryanodine receptor associated disorders comprising a PDE-associated agent and a pharmaceutically acceptable carrier. The present invention also provides methods for treating or preventing ryanodine receptor associated disorders including cardiac disorders and diseases, skeletal muscular disorders and diseases, cognitive disorders and diseases malignant hyperthermia, diabetes and sudden infant death syndrome. The present invention further provides methods for regulating PKA phosphorylation of a ryanodine receptor as well as methods for regulating Ca+2 release and reuptake in cells. Also provided are kits for use in delivering a PDE-associated agent to cardiac cells in a subject, comprising the composition of the present invention and a catheter.
Owner:THE TRUSTEES OF COLUMBIA UNIV IN THE CITY OF NEW YORK

Di-substituted amides for enhancing glutamatergic synaptic responses

This invention relates to compounds, pharmaceutical compositions and methods for use in the prevention and treatment of cerebral insufficiency, including enhancement of receptor functioning in synapses in brain networks responsible for basic and higher order behaviors. These brain networks, which are involved in regulation of breathing, and cognitive abilities related to memory impairment, such as is observed in a variety of dementias, in imbalances in neuronal activity between different brain regions, as is suggested in disorders such as Parkinson's disease, schizophrenia, respiratory depression, sleep apneas, attention deficit hyperactivity disorder and affective or mood disorders, and in disorders wherein a deficiency in neurotrophic factors is implicated, as well as in disorders of respiration such as overdose of an alcohol, an opiate, an opioid, a barbiturate, an anesthetic, or a nerve toxin, or where the respiratory depression results form a medical condition such as central sleep apnea, stroke-induced central sleep apnea, obstructive sleep apnea, congenital hypoventilation syndrome, obesity hypoventilation syndrome, sudden infant death syndrome, Rett syndrome, spinal cord injury, traumatic brain injury, Cheney-Stokes respiration, Ondines curse, Prader-Willi's syndrome and drowning. In a particular aspect, the invention relates to compounds useful for treatment of such conditions, and methods of using these compounds for such treatment.
Owner:CORTEX PHARMA

Infant respiratory monitoring system

The present invention provides a method and apparatus for monitoring infant respiration during sleep. More specifically, the present invention alerts the caregiver when an infant has ceased to breathe during sleep. The usefulness of such device applies to Sudden Infant Death Syndrome (SIDS) and prolonged apnea leading to a life threatening event. One embodiment of a method according to the present invention comprises monitoring the relative level of humidity from an infant respiration and comparing it to the room ambient relative humidity. A determination is made when an infant has stopped breathing once the level of the humidity from the infant breaths approaches the room humidity level. At such time, the present invention provides an alert to the caregiver to allow appropriate actions to be taken in reviving or waking the infant as applicable.
Owner:SILPACHAI OHLAN +1

Prevention of sudden infant death

PCT No. PCT / SE96 / 01428 Sec. 371 Date May 7, 1998 Sec. 102(e) Date May 7, 1998 PCT Filed Nov. 6, 1996 PCT Pub. No. WO97 / 17612 PCT Pub. Date May 15, 1997A method for identification of an infant being particularly susceptible to sudden infant death syndrome (SIDS) comprises the determination of an Helicobacter pylori infection in the infant's mother, particularly by detection of antibodies to H. pylori of the IgG type, in a blood sample drawn from the infant's mother or by determination of carbon dioxide formed from urea in the air exhaled from the infant's mother upon oral administration of a challenge dose of urea. Also disclosed is the use of an antibiotic effective against H. pylori for the manufacture of a medicament for administration to mothers and other persons infected by H. pylori and coming into close bodily contact with infants below two years of age, and a method of prevention of SIDS by administration of that antibiotic.
Owner:OREXO AB

Apparatus and method for wireless autonomous infant mobility detection, monitoring, analysis and alarm event generation

Systems and methods for detecting, monitoring and profiling / correlating a subject's motions, such as rollovers, falls, shaking and tremors are disclosed. In particular, an infant's mobility event may cause critical event processing indicating that an infant has rolled over and may be suffocating. Such an event is classified as a Sudden Infant Death Syndrome (SIDS)-like event. The system may include a wireless pendant device and a wireless monitor server. The wireless pendant device is configured to measure acceleration motion of a subject, to generate acceleration data from the acceleration motion and to communicate the acceleration data with the wireless monitor server. The wireless monitor server is configured to analyze the acceleration data communicated by the wireless pendant device and to provide an output related to the analysis.
Owner:24EIGHT

Monitoring system for sudden infant death syndrome for blind and deaf parents

A monitoring system for sudden infant death syndrome alerts parents, including parents who are blind and deaf, of changes in their infant's health condition. The system comprises three parts: a portable monitoring and warning control unit, a sensor bracelet that would be placed around the infant's wrist and an alarm bracelet for blind and deaf parents. The infant sensor bracelet comprises multiple sensors and a microphone and transceiver to receive and transmit data to a portable control monitoring unit. A similar system is provided for blind and deaf parents. The vibration alarm units each have Braille characters printed in the top to enable a blind person to identify the vibration alarm. A portable monitoring and warning control unit comprises at least a transceiver to communicate with the bracelets and a processing control unit to collect data and compare it with thresholds / acceptable ranges.
Owner:ALI SALAH ABDULLAH

Methods for the treatment of respiratory depression

This invention relates to compounds, pharmaceutical compositions and methods for use in the prevention and treatment of cerebral insufficiency, including enhancement of receptor functioning in synapses in brain networks responsible for basic and higher order behaviors. These brain networks, which are involved in regulation of breathing, and cognitive abilities related to memory impairment, such as is observed in a variety of dementias, in imbalances in neuronal activity between different brain regions, as is suggested in disorders such as Parkinson's disease, schizophrenia, respiratory depression, sleep apneas, attention deficit hyperactivity disorder and affective or mood disorders, and in disorders wherein a deficiency in neurotrophic factors is implicated, as well as in disorders of respiration such as overdose of an alcohol, an opiate, an opioid, a barbiturate, an anesthetic, or a nerve toxin, or where the respiratory depression results form a medical condition such as central sleep apnea, stoke-induced central sleep apnea, obstructive sleep apnea, congenital hypoventilation syndrome, obesity hypoventilation syndrome, sudden infant death syndrome, Rett syndrome, spinal cord injury, traumatic brain injury, Cheney-Stokes respiration, Ondines curse, Prader-Willi's syndrome and drowning, hi a particular aspect, the invention relates to bicyclic amide compounds useful for treatment of such conditions, and methods of using these compounds for such treatment.
Owner:CORTEX PHARMA

Aid for the prevention of sudden infant death syndrome

The present invention provides a safety apparatus as an aid for the prevention of Sudden Infant Death Syndrome: A mattress, fitting the dimensions of a standard-sized crib, is composed of three different layers, allowing a free flow of air through it to the infant lying in any position. The lowest layer has transverse channels allowing cross-wise air movement. The middle and top layers have vertical perforations through them allowing a vertical flow of air. Being composed of 3 layers, differing in density and firmness, the mattress is both firm and pleasant to the touch. Therefore, in addition to its primary function, the mattress provides a method to counter a potential delay in the motor development of the infant, which can result from prolonged lying in the supine position. A mesh sheet is stretched taut over the mattress and fastened securely to the vertical bars of the crib.
Owner:GABBAI MOSHE

Infant remote monitoring system

An infant remote monitoring system utilizes a heat detector to monitor the baby temperature from breath to prevent from the Sudden Infant Death Syndrome (SIDS).
Owner:SOUTHERN TAIWAN UNIVERSITY OF TECHNOLOGY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products